Sequential Treatment with Lamivudine and Peg-interferon Therapy in Patients with E-positive Chronic Hepatitis B and High Viral Load
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2016, Vol 12, Issue 4
Abstract
Background: Patients with chronic hepatitis B virus (HBV) who are positive for e antigen (HBeAg) and have a high viral load are considered to be poor therapeutic responders to pegylated interferon (PEG-IFN). The aim of this study was to assess the therapeutic response of sequential therapy, lamivudine (LAM) followed by PEG-IFN, in these cases. Methods: Chronic HBV patients who were HBeAg positive, with HBV DNA over 107 IU/ml and ALT 2-10 times the upper normal limit, and who were treatment naive were included in our study. Those with concurrent hepatitis C or HIV infection, liver cirrhosis or decompensated cirrhosis, or pregnancy were excluded. The enrolled cases received therapy with PEG-IFN monotherapy for 48 weeks (PEG-IFN group) or sequential therapy with lamivudine (LAM) for 4 weeks followed by PEG-IFN therapy for 48 weeks (LAM/ PEG-IFN group). Results: There were 10 patients in each group, and there were no differences in age, gender, HBV genotype, pre-treatment ALT, and HBV DNA levels between the two groups. The biochemical, virological and serologic responses within 24 weeks after treatment were 40%-60%, 30-50%, and 40-50%, respectively, in the PEG-IFN group, compared with 70%, 20-40%, and 20-40%, respectively, in the LAM/PEG-IFN group. The rates of positive EOT were 30% and 10% in the PEG-IFN group and the LAM/PEG-IFN group, respectively, with rates of 40% and 10% in the SVR-12-week subgroup, and 30% and 20%, respectively, in the SVR-24-week subgroup. The therapeutic responses between the two groups showed no differences. Conclusion: In chronic HBV patients who were positive for HBeAg positive and with a high viral load at baseline, similar therapeutic responses were noted between the sequential LAM/PEG-IFN therapy group and the PEG-IFN monotherapy group. Further research with a higher number of patients and a prolonged LAM course are needed to confirm the efficacy of this approach.
Authors and Affiliations
Shou-Wu Lee, Sheng-Shun Yang, Teng-Yu Lee, Hong-Zen Yeh, Chi-Sen Chang
Surgical Management of Haemangiolymphangioma - An Infrequent Tumor in Oral Cavity: A Case Report and a Review
Hemangiomas are group of vascular anomalies which are not present at birth. They generally manifest within 3-4 weeks of life, consists of a rapid proliferative phase, stable plateau phase and slow involuting phase. Heman...
Correlation of MRI Findings of Intervertebral Disc Water Content and Disc Height with Self-rated Quality of Life, Pain and Disability
Aims: To investigate (1) the correlation between MRI findings of Intervertebral disc water content and disc height, with self-rated quality of life (QoL), pain, and disability respectively, and (2) the correlation betwee...
Evaluation of Two Commonly Used Commercial Immunochromatographic and ELISA Screening Kits for the Detection of Anti-HCV Antibodies among Patients in North Central Nigeria
Background: Hepatitis C Virus infection presents a major public health threat globally. The advent of different immunoassays for the detection of specific markers for the diagnosis of the infection since the discovery of...
Multıple Myeloma wıth Homogenous Secretıon of Lambda Lıght Chaın Immunoglobulın: A Case Report
About 20% of people with multiple myeloma (MM) produce only light kappa chains which is produced in 80% of cases. This population of MM patients may be missed where the laboratory could not effectively detect free light...
Non-Helicobacter pylori, Non-NSAID Peptic Ulcer Disease: An Important Consideration in the Evaluation of Patients with Gastric or
Peptic ulcers are common although the pattern of aetiology is changing. The traditionally most frequent causes of Helicobacter pylori infection and non-steroidal anti-inflammatory toxicity are likely to assume less relat...